- Press releasesPress releases
- Events & ActivityEvents & Activity
- TherapeuticsMD to Host Second Quarter Financial Results Conference Call and Webcast on August 3
- TherapeuticsMD Provides TX-004HR Regulatory Update
- June 19 Deadline Alert: GPM Reminds Investors of Looming Deadline in the Class Action Lawsuit Against TherapeuticsMD, Inc.
- The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of TherapeuticsMD, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2017
- The Klein Law Firm Announces a Class Action Filed on Behalf of TherapeuticsMD, Inc. Shareholders and a Lead Plaintiff Deadline of June 19, 2017
- TherapeuticsMD Announces Presentation at Jefferies 2017 Healthcare Conference on June 8
- TherapeuticsMD Announces Presentation at Bank of America Merrill Lynch 2017 Healthcare Conference on May 16
- TherapeuticsMD Receives Complete Response Letter from FDA for TX-004HR New Drug Application
- TherapeuticsMD to Host TX-004HR Regulatory Update Conference Call and Webcast on May 8
- TherapeuticsMD Announces First Quarter 2017 Financial Results
TherapeuticsMD Inc (TXMD:ASQ) closed at 5.69, 62.57% above the 52 week low of 3.50 set on May 08, 2017.
3.50May 08 20178.30Apr 06 2017
Markit short selling activity
|Market cap||1.16bn USD|
|EPS (TTM)||-0.4579 |
Data delayed at least 15 minutes, as of Jul 21 2017 21:00 BST.